Saudi Arabia to become destination for pharmaceutical sector: Fitch Solutions

Saudi Arabia’s pharmaceutical market was valued at SR44 billion in 2022 and is expected to reach SR56.6 billion in 2027 with a compound annual growth rate of 5.2 percent. (Shutterstock)
Short Url
Updated 13 July 2023
Follow

Saudi Arabia to become destination for pharmaceutical sector: Fitch Solutions

RIYADH: Saudi Arabia’s business landscape is expected to see a surge in investments from the pharmaceutical sector, with growing demand for healthcare services and increasing fundraising activity in the industry, according to Fitch Solutions, the research arm of US-based Fitch Ratings. 

Pharmaceutical companies have shown a growing inclination toward investing in the Kingdom in recent years, attracted by the country’s large and increasing population, strong healthcare infrastructure, and the government’s dedicated efforts to develop the sector as part of its Vision 2030 plan.

Several multinational pharmaceutical giants such as Novartis, Pfizer, Sanofi, Merck, and GlaxoSmithKline have established a presence in Saudi Arabia through direct investment or partnerships with local companies. 

In May, Jamjoom Pharma achieved one of the largest initial public offerings in the Kingdom. The company successfully raised SR1.26 billion ($340 million) by pricing its shares at SR60 each, marking the top end of the price range.

“The IPO signifies that pharmaceutical companies are willing to go public and raise capital from the stock market, reflecting growing confidence in the economy’s growth potential and the investment climate in Saudi Arabia,” said Fitch Solutions in its analysis of the Kingdom’s growing industry. 

The escalating demand for healthcare services is a significant catalyst for pharmaceutical investment in Saudi Arabia. With a population exceeding 34 million people, the Kingdom’s healthcare system faces mounting pressure to cater to the needs of its residents.

“This demand is driven by factors such as an aging population, the rise of chronic diseases, and the increasing public awareness of healthcare issues,” pointed out the analysis. 

According to Fitch Solutions, Saudi Arabia’s pharmaceutical market was valued at SR44 billion in 2022 and is expected to reach SR56.6 billion in 2027 with a compound annual growth rate of 5.2 percent. 

The government has also implemented regulatory reforms to encourage investment and support the development of the local pharmaceutical industry. 

Besides the domestic market, Saudi Arabia’s strategic location and strong logistics infrastructure make it an attractive base for pharmaceutical companies looking to expand their presence in the wider region. 

“Many companies have established regional headquarters or distribution centers in the country, using it as a hub to serve other markets in the Middle East and North Africa region,” added Fitch Solutions. 

 


Global Markets: Asian stocks fall as Iran war keeps oil at $100, upends rate outlook

Updated 13 March 2026
Follow

Global Markets: Asian stocks fall as Iran war keeps oil at $100, upends rate outlook

  • Asian stocks set for consecutive weeks in the red
  • Traders rapidly cut Fed rate cut ‌wagers for the year
  • Investors focus on oil prices, inflation risks

SINGAPORE: Asian stocks slumped on Friday, poised for a second straight weekly decline as fast-dwindling hopes of a resolution to the US ​and Israel’s war with Iran kept oil prices aloft, casting a shadow over global markets and spurring inflation fears.

The US dollar has become the safe-haven of choice during the tumult, putting most other currencies under pressure. The dollar was set for a second consecutive week of gains and is up 2 percent since the war broke out at the end of February.

The yen hit its weakest level since July 2024 at 159.69 per US dollar on Friday as Japan warned that it was ready to take action to protect against yen declines. It was last at 159.41.

Analysts said the bar for intervention is higher this time around as any intervention now could prove futile in the face of the relentless dollar buying.

In ‌Asia, MSCI’s broadest ‌index of Asia-Pacific shares slipped 1 percent, on course for a 2.2 percent decline for ​the week. ‌Japan’s ⁠Nikkei fell ​1.4 percent, ⁠while tech-heavy South Korean stocks slid nearly 2 percent.

European futures point to a slightly higher open but may struggle to hold those gains on weak sentiment.

Oil prices remained close to $100 per barrel level, although they eased a bit on Friday after US issued a 30-day license for countries to buy Russian oil and petroleum products currently stranded at sea.

Brent futures were at $100.70 a barrel at 9:47 a.m. Saudi time, while West Texas Intermediate crude was at $95.59. They were both hovering around $60 levels at the start of 2026.

“Headlines are coming at the market like water from a fire hose, which is impacting the price of oil, and consequently, financial markets,” said Mitch ⁠Reznick, group head of fixed income at Federated Hermes.

“The question remains to what extent ‌we are caught in the $80-plus range even as the headlines become ‌banal with their frequency and contradictions.”

With Iran stepping up attacks across the Middle ​East as its new Supreme Leader Mojtaba Khamenei vowed to ‌keep the Strait of Hormuz shipping lane closed, investors are bracing for a prolonged conflict and higher oil prices.

The ‌spectre of rising inflation has led markets to rapidly reprice what they expect from central banks this year, with traders now anticipating just 20 basis points of easing from the Federal Reserve compared to 50 bps of cuts priced in last month.

The selloff in global stocks and bonds shows no signs of easing. US stocks fell sharply overnight and the two-year Treasury yields, which typically move in ‌step with Fed interest rate expectations, scaled a six-month high on Thursday.

“With the possibility of higher oil prices still elevated, investors should be prepared for continued volatility and potentially further ⁠downside in the near ⁠term,” said Vasu Menon, managing director of investment strategy at OCBC in Singapore.

Shifting rates outlook

Jose Torres, senior economist at Interactive Brokers, said the impact of rising oil prices on corporate margins, inflation expectations, rate-cut prospects and yields is sparking volatility, leaving participants with few places to hide.

“Indeed, sinking optimism about Fed rate reductions amid strengthening cost pressures is weighing on traditional safe havens such as silver, gold, and government debt.”

The two-year note yield eased 3 bps to 3.730 percent after hitting its highest level since August 22 on Thursday. The yield has gained 35 bps in the two weeks since the war started.

The yield on the longer-dated 30-year bond has risen 24 bps this month.

Investor focus will switch to a slate of policy meetings next week with the Fed, the Bank of Japan, the European Central Bank and the Bank of England all due to meet, with most expected to keep rates unchanged. The Reserve Bank of Australia is broadly expected to hike ​rates next week.

In currencies, the euro was steady ​at $1.15035, on course for a weekly decline of nearly 1 percent. The dollar index was at 99.816, set for about a 1 percent weekly advance.
Gold was 0.4 percent higher at $5,101 per ounce on Friday but set for a 1 percent drop for the week.